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Abstract
The stem cells are part of the cells that belong to the stromal tissue. These cells remain in a 
quiescent state until they are activated by different factors, usually those generated by an 
alteration in the parenchymal tissue. These cells have characteristic membrane markers 
such as CD73, CD90, and CD105. Those are a receptor, which in response to their ligand 
induces strong changes in different metabolic pathways that lead to these cells, both to 
generate molecules with different activities and to leave their stationary phase to repro-
duce and even differentiate. This review describes the metabolic pathways dependent 
on these membrane markers and how they influence on parenchymal tissue and other 
stromal cells.
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1. Introduction
Stromal cells make up some connective tissues for particular organs and give support by 
surrounding other tissues and organs. As result, stromal cells provide support, structure, 
and anchoring for many organs inside the body. The generic term “stromal cells” clearly the 
phenotypic and functional complexity of these cells. In addition, to their main functions in 
helping support organs and acting as connective tissues, stromal cells respond with metabolic 
adaptations to different inductions factors and play an important role in the microenviron-
ment [1]. Stromal cells are able to react to physical and chemical signals of tissue damage. 
Physical stress such as mechanical stress activates channels (SACs) on the cell membrane [2]. 
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
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On cells attached to an extracellular matrix, SACs initiate the remodeling of cell membrane 
structures called integrins. Membrane receptors rapidly send signals to the nucleus which 
initiate the synthesis of proteins, which in turn interact with cell metabolism and the sur-
rounding environment to induce the modulation of recovery of parenchymal tissue function. 
Fibroblasts, pericytes, and stem cells are among the most common types of stromal cells. In 
this chapter, we analyze the membrane markers of stem cells and assess their capacity to 
influence surrounding tissues and recover tissue functionality.
2. How adult stem cell markers work?
Stem cells are composed of multiple types of cells, and all of them are characterized as undif-
ferentiated cells able to self-renew and proliferate with high capacity. The international soci-
ety for cellular therapy minimal criteria to define human MSC: (1) Mesenchymal stem cells 
(MSC) must be plastic adherent in standard culture conditions. (2) MSC must express CD105, 
CD73, and CD90, and lack expression of CD45, CD34, CD14 or CD11b, CD79a or CD19, and 
HLA-DR surface molecules. (3) MSC must differentiate to osteoblasts, adipocytes, and chon-
droblasts in vitro [3, 4]. Membrane markers are also present on other cells with high prolifera-
tion rates such as in the intestinal epithelium, ischemic myocardium, cholinergic synapses 
and in proliferative lymphocyte, and tumoral cells.
This review aims to analyze why those membrane markers are important to maintain impor-
tant characteristics of stem cells such as proliferation potential, angiogenic, differentiation, 
and immunomodulation capacity. We assess how membrane markers promote the growth, 
proliferation, differentiation, and survival of parenchymal cells where stem cells reside. These 
cell membrane markers contribute under appropriate stimuli to the capacity of stem cells to 
differentiate into endoderm, mesoderm, or ectoderm-derived cell tissues.
2.1. CD73 membrane marker
CD73 participates in an autocrine and paracrine manner to the regulation of a variety of phys-
iological processes. The primary structure of CD73 was described by Misumi et al. [5] as a 
dimer of two identical 70-kD subunits bound by a glycosylphosphatidylinositol linkage to 
the external face of the plasma membrane. This molecule is an ecto-5′-nucleotidase, which 
dephosphorylates nucleoside adenosine monophosphate (AMP) into adenosine (ADO). ADO 
is a potent endogenous physiological and pharmacological regulator of many functions. ADO 
mediates its effects on tissue regeneration and repair via binding and activation of a fam-
ily of G protein-coupled receptors (adenosine A1, A2A, A2B, and A3 receptors). Activation 
of the G protein activates the PKA pathway by activating cyclic AMP. PKA is an enzyme 
that transfers a phosphate group from ATP to other specific proteins such as the cyclic AMP 
response element-binding protein (CREB). PKA is a transcriptional coactivator that stimu-
lates the transcription of several genes by a phosphorylation pathway of kinases. Between 
those kinases, extracellular signal-regulated kinases (ERK) activate many transcription fac-
tors such as activating protein 1 (AP1). AP1 controls a number of cellular processes including 
 differentiation, proliferation, and apoptosis [6–8]. Being one of the target genes of Cyclin D, 
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AP1 transcription factors are also associated with tissue regeneration. Cyclin D is a protein 
involved in regulating cell cycle progression by regulating the G1–to-S phases [9]. AP1 also 
induces CREB, another transcription factor responsible for increasing or decreasing the tran-
scription of downstream genes [10]. The presence of CD73 in the cell membrane allows this 
enzyme to release ADO from extracellular AMP. ADO then binds to a membrane receptor 
associated with the G protein. Activation of the G protein induces a phosphorylation cas-
cade that allows the activation of transcription factors. The target genes of these transcription 
factors are those involved with the cell cycle, the synthesis of extracellular matrix, and vas-
cular growth factors (Figure 1). Nevertheless, activation of these receptors induces variable 
responses in different cells.
The pathway generates the liberation of extracellular ADO and could be responsible for the 
angiogenic effects observed in stem cell transplantation. Because of the dephosphorylate 
enzymatic activity of CD73 on AMP, the pathway induces the synthesis of VEGF. Indirectly, 
CD73 is responsible for the angiogenic capacity of stem cells as generating ADO by auto-
crine signaling will consequently stimulate the production of VEGF, a pro-angiogenic factor. 
For example, in skeletal muscle cells, activated PKA phosphorylates enzymes involved in 
glycogen metabolism which simultaneously trigger the breakdown of glycogen to glucose 
and inhibit glycogen synthesis, thereby increasing the amount of glucose available to muscle 
cells within seconds. In macrophages, it also induces the synthesis of angiogenic factors, such 
as VEGF and the proliferation of human retinal endothelial cells [11–13]. The pathway also 
plays an important role in the proliferation of endothelial cells. Stimulation of A2A recep-
tors could be responsible for wound healing by stimulating both angiogenesis and matrix 
production [14]. Montesinos et al. [15] proposed that ADOA2A receptor stimulation by ADO 
promotes the recruitment of circulating bone marrow-derived endothelial precursor cells and 
 differentiation into endothelial cells. CD73 serves as a costimulatory molecule in activating 
T cells [16].
Figure 1. Schematic CD73 signaling pathways. The activity of ectonuclease on extra-cytoplasmic AMP releases (ADO). 
ADO binds to its receptor which in turn generates the activation of the G protein and triggers the phosphorylation 
cascade up to transcription factors that will induce the expression of genes responsible for the synthesis of collagen and 
vascular endothelial growth factors (VEGF).
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Several activities for CD73 and its product ADO have been described, including interactions 
of ADO with its receptor in hematopoietic cells given the activation and angiogenic capa-
bilities of those cells. Probably, in stem cells, the CD73 transmembrane protein is related to 
the capacity of cells to differentiate into several lineages because the A2A receptor has been 
inoculated as a possible regulator of osteoblast differentiation in bone tissues [17]. The path-
way generated by this membrane marker induces the synthesis of extracellular matrix and 
promotes collagen production in the skin and in the liver [18–20].
Another activity observed in stem cells is their immunomodulatory potential, which is related 
to ADO inhibition against inflammatory actions by neutrophils [21]. ADO is also a neuro-
modulator acting through A1 and A2 receptors. A1Rs are abundantly expressed throughout 
the brain and control synaptic transmission. Because of its participation in cAMP formation 
in synaptosomes, CD73 has been proposed as an alternative target in the treatment of some 
cases of synaptic degeneration and neurodegeneration [22, 23].
CD73 has been related with cardiopathies as ADO produced by the 5′-nucleotidase activity 
of CD73 could exert control over the mineralization of the aortic valve [24]. Development and 
maturation of arterial atherosclerotic plaques have been related to the impaired expression of 
CD73. The production of ADO by CD73 is critical for adaptation to hypoxia in the myocar-
dium, where CD73-catalyzed ADO production acts as a critical control point for the mainte-
nance and regulation of vascular barrier function in multiple tissues under hypoxia [25, 26].
Other stromal cells bearing CD73 are fibroblasts, which are the most common cells in connec-
tive tissues. Fibroblasts synthesize the extracellular matrix that includes collagen, glycosami-
noglycans, elastic fibers, and glycoproteins, as well as participate in inflammatory responses. 
Fibroblasts aid to maintain the structural integrity of connective tissues [27–29]. On those 
activities are involved with the CD73 membrane marker that allows the activation of the 
G-protein followed by a pathway to induce the activation of the transcription factors respon-
sible for the synthesis of extracellular matrix molecules.
2.2. CD90 membrane marker
Early studies on THY1 and CD90 have suggested their possible relation with cell activation 
in progenitor’s cells with the highest in vitro proliferative potential [30]. THY1 is signaled via 
integrins, protein tyrosine kinases, cytokines, and growth factors. Several functions have been 
related to THY1 such as T-cell activation, neurite outgrowth, apoptosis, tumor suppression, 
wound healing, and fibrosis [31–34]. In order to understand how this membrane receptor 
induces so many changes in cellular metabolism, numerous studies have been conducted to 
identify possible activation pathways induced by the activation of THY1. THY1 is a glyco-
phosphatidylinositol (GPI) anchored to conserved cell surface protein with a single V-like 
immunoglobulin domain. The protein is anchored in the external lipid bilayer of the mem-
brane by a phosphatidylinositol (PI) anchor in membrane microdomains (lipid rafts) [35, 36].
Studies focusing on understanding why this membrane protein induces several changes in 
cellular pathways have reported that THY1 stimulates neurite outgrowth by activating a 
second messenger pathway where extracellular signals such as growth factors. Its activation 
induces a rapid and extensive mobilization of the intracellular second messengers, PI, and 
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Ca2+ [37]. T-cell activation by THY1 causes an immediate phosphatidylinositol (PI) turnover 
and an influx of extracellular Ca2 while releasing very little Ca2+ from intracellular stores [38]. 
Intracellular transduction of the G protein activates phospholipase C that generates inositol 
phosphate and diacylglycerol (a second messenger) groups from the hydrolysis of plasma 
membrane phospholipids. Inositol phosphate could be phosphorylated at various positions 
by enzymes that belong to the family of phosphatidylinositol 5-phosphate 4-kinases. The 
resulted PI is a second messenger involved in several signaling pathways including signals 
of cell growth [39–42]. IP3 releases Ca2+ from the endoplasmic reticulum by binding to its 
receptors (IP3R) regulating mitochondrial metabolism, cell cycle entry, and cell survival. Ca2+ 
signals are important for the self-renewal and differentiation of human embryonic stem cells 
[43–45]. Ca2+ forms a complex with the protein calmodulin which regulates the activity of 
many proteins including various transcription factors [46, 47]. Diacylglycerol is a glyceride 
of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages and 
it remains within the plasma membrane where it regulates the protein kinase signaling cas-
cades through protein kinase C (PKC) activation [48].
High capacity for cell proliferation is induced via CDk5 and ERK, generating changes in the 
cytoskeleton that induce cell proliferation and differentiation, matrix production and immu-
nomodulatory potential. Recently, Chung et al. [49] demonstrated that a subpopulation that 
is positive for THY1 (CD90) is relatively more capable of forming bone than the CD105 low 
subset of cells. Considering the possible differentiation and proliferation capacity of cells car-
rying this membrane protein, stromal cardiac cells with the CD90 antigen were introduced 
to recover function, and reprogramming capacities in an infarcted heart. Cells obtained from 
human bone marrow-bearing this membrane marker exhibited robust multi-lineage differ-
entiation and self-renewal potency. In addition, THY1 expression appears to be an indicator 
of G0/G1cell-cycle phase in human stem cells from bone marrow [50–53]. THY1 has possible roles in cell–cell interaction where THY1 mediates adhesion of leukocytes and monocytes to 
endothelial cells and fibroblasts and performs a signaling event, which results in the activa-
tion of cell pathways.
THY1 is a receptor to many molecules such as growth factors, hormones, and the extracellular 
matrix. Its stimulation induces the synthesis of second messengers that initiate a cascade of 
reactions that can lead to the cell to proliferation or differentiation (Figure 2).
In fibroblasts expressing the endometrial stromal marker CD90 (THY1) [54], CD90 was 
strongly expressed by functional stroma and perivascular cells and used to isolate pure popu-
lations of endometrial stromal stem and progenitor cells [55]. In fibroblasts, these membrane 
markers are stimulated by peptide growth factors, such as bombesin and PDGF, thereby 
inducing DNA synthesis and cell division. In addition, since apoptosis is a mechanism dur-
ing normal wound healing, THY1 has a beneficial effect on lung fibroblast activity where it 
induces the regulation of apoptosis via Fas-, Bcl-, and caspase-dependent pathways [56].
2.3. CD105 membrane marker
Endoglin, a cell membrane glycoprotein also known as CD105, is over-expressed in pro-
liferating endothelial cells and as consequence is involved in neovascularization. It is a 
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 transmembrane glycoprotein related to the transforming growth factor (TGF)-β receptor. 
St-Jaques et al. [57] suggested that endoglin on stromal fibroblast-like cells may be regulating 
the access of TGF-β1 to the signaling receptor complex. It was later confirmed that CD105 is 
a transmembrane protein that binds to several factors of the TGF-β superfamily, a pleiotropic 
cytokine that regulates different cellular functions including proliferation, differentiation, 
and migration [58]. Endoglin binds TGF-β1 and TGF-β3 with high affinity through its asso-
ciation with the TGF-β receptor type II [59]. After TGF-β binding to its receptor via two single 
pass serine/threonine kinase transmembrane proteins, a phosphorylate kinase activates sig-
naling cascade transduction, which initiates intracellular signaling by phosphorylating mem-
bers of the Smad family of transcription. The resulting Smad heterocomplex translocates into 
the nucleus and interacts with numerous transcription factors that in turn regulate the tran-
scription of many TGF-β-responsive genes [60, 61]. Upon ligand stimulation, R-Smads are 
phosphorylated by receptors and form oligomeric complexes with common-partner Smads 
(Co-Smads). Oligomeric Smad complexes then translocate into the nucleus where they regu-
late the transcription of target genes by direct binding to DNA. CD105 co-stimulates the 
TGF-β receptor to induce CDk5 and other genes by the Smad4 pathway leading to high cell 
proliferation and collagen production (Figure 3).
Figure 2. Schematic representation of CD90 pathway induction. GPI is anchored in the cell membrane surface and its 
activation generates an efflux of calcium and a release of phosphatidylinositol (PI). These second messengers regulate 
mitochondrial metabolism, cell cycle entry, and cell survival.
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The biological functions of TGF-β can only be delivered after ligand activation and they pro-
mote or inhibit cell proliferation. The activation of TGF-β is involved in the recruitment of stem 
and progenitor cell participation in the tissue regeneration and remodeling process [62, 63].
In some cases, the expression of endoglin has been related to its differentiation selectivity. 
Levi et al. [64] found that a subset of adipose-derived stem cells with low expression of the 
endoglin cell surface receptor (CD105) had enhanced in vitro and in vivo osteogenic differ-
entiation potential. Nevertheless, more recent research in an osteoarthritis animal model has 
reported that CD105+-MSCs migrated toward the injured knee joint and suggested the use of 
CD105+-MSC as an alternative for cell therapy for these pathologies [65, 66]. Because CD105 is 
a co-factor component of the TGF-β receptor complex that is expressed in endothelial cells, it 
has been related to the pathogenesis of vascular diseases and with tumor progression [67, 68]. 
Nevertheless, TGF-β has been shown to activate two distinct pathways, ALK5-inducing 
Smad2/3 phosphorylation, and ALK1-promoting Smad1/5 phosphorylation. Those pathways 
regulate endothelial cell proliferation. Activation of ALK1 stimulates cell proliferation and 
migration, whereas activation of ALK5 inhibits these responses [69, 70]. Cell therapy may 
reconstitute the entire hematopoietic system with cells bearing CD105. Since TGF-β1 exerts its 
action on primitive hematopoiesis by inhibiting cell cycle progression of primitive precursors, 
Figure 3. Schematic representation of CD105 pathways. The membrane protein binds to the transforming growth factor 
receptor (TGFr). Following TGF binding with its receptor, a signaling cascade leads the transcription of different genes 
related to cell differentiation, chemotaxis, proliferation, and activation across many cells.
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a previous report has shown that the presence of cells bearing CD34 represents an option to 
recover hematopoietic stem cells. Recently, it has been reported that human stem cells bear-
ing CD34 and CD105 are the best long-term repopulating cells and present high self-renewal 
capacities [71, 72]. Nevertheless, balance is very important and these cells have been related 
to pathologies such as fibrosis diseases [73, 74].
3. Conclusions
The membrane markers CD73, CD90, and CD105 allow stem cells and other stromal cells 
such as fibroblasts to react to stimuli and quickly leave their quiescent state, thereby going 
into a proliferation state and generating growth factors. Those capacities allow the recovery 
of parenchymal tissue in which they are found. CD73 is an ectoenzyme that dephosphory-
lates nucleoside AMP given free ADO. This purine binding to its membrane receptor leads 
to the activation of the G protein and results in the activation of a pathway that reaches 
the nucleus. As a consequence, extracellular matrix and growth factors such as VEGF are 
synthesized. CD90 influences the cell cycle and cell proliferation. CD90 also induce several 
cytoskeletal changes allowing cell differentiation. CD105 is a co-factor to the TGF-β receptor 
and following TGF-β union with its receptor a signaling cascade is activated, resulting in the 
transcription of different effectors including the synthesis of pro-inflammatory cytokines, 
which have an important role in angiogenesis and proliferation. In conclusion, those mem-
brane markers are related to pathways that regulate the immune response, cell proliferation, 
and differentiation, thereby allowing lost tissue recovery and the formation of new angio-
genic pathways.
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